Zobrazeno 1 - 10
of 190
pro vyhledávání: '"recombinant protein vaccine"'
Autor:
Yuanda Xu, Xuetao Kong, Weiqing Huang, Zijing Liang, Jinkun Huang, Yimin Li, Nuofu Zhang, Dan Liu, Wenwei Guo, Jiang Mei
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractBackground Despite the widespread administration of coronavirus disease 2019 (COVID-19) vaccines, the impact on patients with asymptomatic to mild illness remains unclear. Here, we aimed to assess the efficacy of various vaccine doses and typ
Externí odkaz:
https://doaj.org/article/75cb2dd207f14c6e9cd983e1c24892b7
Autor:
Wen Jia, Li Zihua, Lv Yongxue, Ding Shuqin, Zhu Yazhou, Yang Jihui, Tang Jing, Zhu Mingxing, Zhao Yinqi, Zhao Wei
Publikováno v:
Acta Biochimica et Biophysica Sinica, Vol 56, Pp 879-891 (2024)
Brucellosis is a global zoonotic infection caused by Brucella bacteria, which poses a significant burden on society. While transmission prevention is currently the most effective method, the absence of a licenced vaccine for humans necessitates the u
Externí odkaz:
https://doaj.org/article/fab1ecc0528d4d11957c513f5d9cab5c
Autor:
Joon Young Song, Won Suk Choi, Jung Yeon Heo, Eun Jin Kim, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Byung Wook Yoo, In-Jin Jang, Maria Z. Capeding, François Roman, Thomas Breuer, Piotr Wysocki, Lauren Carter, Sushant Sahastrabuddhe, Manki Song, Naveena D'Cor, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Hee Jin Cheong, Agathe Philippot, Francesca Solmi, Maria Angeles Ceregido, Byoung-Shik Shim, Sang Hwan Seo, Simone D'Souza, Patchara Thaisrivichai, Josefina Carlos, Edison Alberto, Sorachai Nitayaphan, Winai Ratanasuwan, Piroon Mootsikapun, Romanee Chaiwarith, Luong Chan Quang, Olena Karpenko, Tatiana Yurkiv, Vitalii Kutovyi, Angela Bartko, Olga Gyrina, Olga Barna, Mykhailo Pugach, Claire Thurlow, Simon Carson, Susan Smith, Mike Williams, Tiwini Hemi Senior, Tim Humphrey, Davitt Sheahan, Hokeun Park, Yoon Yeong Lee, Seung Gu Kang
Publikováno v:
EClinicalMedicine, Vol 64, Iss , Pp 102140- (2023)
Summary: Background: GBP510 vaccine contains self-assembling, recombinant nanoparticles displaying SARS-CoV-2 spike receptor-binding domains. We report interim phase 3 immunogenicity results for GBP510 adjuvanted with AS03 (GBP510/AS03) compared with
Externí odkaz:
https://doaj.org/article/608a2ee1e423411eb689bce93946af34
Autor:
Guang-Wei Feng, Zhong-Fang Wang, Peng He, Qin-Ying Lan, Ling Ni, Ya-Zheng Yang, Chen-Fei Wang, Ting-Ting Cui, Li-Li Huang, Yong-Qiang Yan, Zhi-Wei Jiang, Qing Yang, Bang-Wei Yu, Xi Han, Jing-Jing Chen, Shu-Yuan Yang, Lin Yuan, Ling-Yun Zhou, Ge Liu, Ke Li, Zhen Huang, Jin-Cun Zhao, Zhong-Yu Hu, Zhi-Qiang Xie
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
This was a phase 1 dose-escalation study of ZR202-CoV, a recombinant protein vaccine candidate containing a pre-fusion format of the spike (S)-protein (S-trimer) combined with the dual-adjuvant system of Alum/CpG. A total of 230 participants were scr
Externí odkaz:
https://doaj.org/article/6249aea6fd484c219325ab664a394757
Autor:
Cai He, Aqu Alu, Hong Lei, Jingyun Yang, Weiqi Hong, Xiangrong Song, Jiong Li, Li Yang, Wei Wang, Guobo Shen, Guangwen Lu, Xiawei Wei
Publikováno v:
MedComm, Vol 4, Iss 3, Pp n/a-n/a (2023)
Abstract The XBB.1.5 subvariant has drawn great attention owing to its exceptionality in immune evasion and transmissibility. Therefore, it is essential to develop a universally protective coronavirus disease 2019 vaccine against various strains of O
Externí odkaz:
https://doaj.org/article/4516bdfab07e4c0b9dcf39d0d532b923
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiaqing Zhang, Yao Wang, Chengyang Hu, Pengpeng Xu, Liguo Ma, Lei Liu, Jie Sun, Yang Liu, Hui Yang, Fan Pan, Jieying Hu, Chengsong Cao, Kai Cheng, Dawei Gao, Yong Lyu, Wei Qin
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Real-world evidence on the effectiveness of COVID-19 vaccines marketed in China against the Omicron BA.2.2 variant remains scarce. A case–control study was conducted to estimate the vaccine effectiveness (VE) of COVID-19 vaccines marketed in China
Externí odkaz:
https://doaj.org/article/7bf502ebffa941ef974c60535c04411b
Autor:
Joon Young Song, Won Suk Choi, Jung Yeon Heo, Jin Soo Lee, Dong Sik Jung, Shin-Woo Kim, Kyung-Hwa Park, Joong Sik Eom, Su Jin Jeong, Jacob Lee, Ki Tae Kwon, Hee Jung Choi, Jang Wook Sohn, Young Keun Kim, Ji Yun Noh, Woo Joo Kim, François Roman, Maria Angeles Ceregido, Francesca Solmi, Agathe Philippot, Alexandra C. Walls, Lauren Carter, David Veesler, Neil P. King, Hun Kim, Ji Hwa Ryu, Su Jeen Lee, Yong Wook Park, Ho Keun Park, Hee Jin Cheong
Publikováno v:
EClinicalMedicine, Vol 51, Iss , Pp 101569- (2022)
Summary: Background: Vaccination has helped to mitigate the COVID-19 pandemic. Ten traditional and novel vaccines have been listed by the World Health Organization for emergency use. Additional alternative approaches may better address ongoing vaccin
Externí odkaz:
https://doaj.org/article/80ddadf93d8141ebb97f5b2dfc32f0bc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.